Early inflammatory changes in the "perilesional skin" of psoriatic plaques: Is there interaction between dendritic cells and keratinocytes?

Journal of Investigative Dermatology

Volumn 127, Issue 8, 2007, Pages 1915-1922

  Komine, Mayumi ^a   Karakawa, Masaru ^a   Takekoshi, Tomonori ^a   Sakurai, Naoki ^a   Minatani, Yosaku ^a   Mitsui, Hiroshi ^a   Tada, Yayoi ^a   Saeki, Hidehisa ^a   Asahina, Akihiko ^a   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CCAAT ENHANCER BINDING PROTEIN BETA; CD3 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CYTOKERATIN 16; CYTOKERATIN 6; CYTOKINE; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; LANGERIN; T6 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL INTERACTION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; KERATINOCYTE; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS VULGARIS; SKIN DEFECT; SKIN INFLAMMATION; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD1; ANTIGENS, CD3; ANTIGENS, CD80; ANTIGENS, CD86; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL COMMUNICATION; CYTOKINES; DENDRITIC CELLS; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULINS; KERATINOCYTES; LANGERHANS CELLS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PSORIASIS; SKIN;

EID: 34447534308     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700799     Document Type: Article

References (40)

1. Abrams JR, Kelley SL, Hayes E, Kikuchi T, Brown MJ, Kang S et al. (2000) Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. J Exp Med 192:681-94
2. Abrams JR, Lebwohl MG, Guzzo CA, Jegasothy BV, Goldfarb MT, Goffe BS et al. (1999) CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest 103:1243-52
3. Andrew PJ, Harant H, Lindley IJD (1999) Up-regulation of interleukin-1β-stimulated interleukin 8 in human keratinocytes by nitric oxide. Biochem Pharmacol 57:1423-9
4. Banno T, Gazel A, Blumenberg M (2004) Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem 279:32633-42
5. Berthier-Vergnes O, Bermond F, Flacher V, Massacrier C, Schmitt D, Peguet-Navarro J (2005) TNF-alpha enhances phenotypic and functional maturation of human epidermal Langerhans cells and induces IL-12 p40 and IP-10/CXCL-10 production. FEBS Lett 579:3660-8
6. Bos JD, de Rie MA, Teunissen MB, Piskin G (2005) Psoriasis: dysregulation of innate immunity. Br J Dermatol 152:1098-107
7. Bowcock AM, Krueger JG (2005) Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 5:699-711
8. Castelijns FA, Gerritsen MJ, van Vlijmen-Willems IM, van Erp PE, van de Kerkhof PC (1999) The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis. J Am Acad Dermatol 40:901-9
9. Chamian F, Krueger JG (2004) Psoriasis vulgaris: an interplay of T lymphocytes, dendritic cells, and inflammatory cytokines in pathogenesis. Curr Opin Rheumatol 16:331-7
10. Chamian F, Lowes MA, Lin SL, Lee E, Kikuchi T, Gilleaudeau P et al. (2005) Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proc Natl Acad Sci USA 102:2075-80
11. Deguchi M, Aiba S, Ohtani H, Nagura H, Tagami H (2002) Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease. Arch Dermatol Res 294:297-302
12. De Mare S, De Jong E, Van Erp PE, Van de Kerkhof PC (1990) Markers for proliferation and keratinization in the margin of the active psoriatic lesion. Br J Dermatol 122:469-75
13. Elias AN, Nanda VS, Barr RJ (2003) CD1a expression in psoriatic skin following treatment with propylthiouracil, an antithyroid thioureylene. BMC Dermatol 3:3
14. Ellis CN, Krueger GG (2001) Alefacept Clinical Study Group. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. New Engl J Med 345:248-55
15. Frank S, Stallmeyer B, Kampfer H, Kolb N, Pfeilschifter J (1999) Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J 13:2002-14
16. Gilleaudeau P, Sullivan-Whalen M, Wittkowski KM, Papp K, Garovoy M, Dummer W et al. (2005) Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci USA 102:19057-62
17. Gordon KB, Bonish BK, Patel T, Leonardi CL, Nickoloff BJ (2005) The tumour necrosis factor-alpha inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaques. Br J Dermatol 153:945-53
18. Griffiths CE, Voorhees JJ, Nickoloff BJ (1989) Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 20:617-29
19. Haftek M, Faure M, Schmitt D, Thivolet J (1983) Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration. J Invest Dermatol 81:10-4
20. Hill JR, Corbett JA, Kwon G, Marshall CA, McDaniel ML (1996) Nirtic oxide regulates interleukin 1 bioactivity released from murine macrophages. J Biol Chem 271:22672-8
21. Kinoshita S, Akira S, Kishimoto T (1992) A member of the C/EBP family, NF-IL6 beta, forms a heterodimer and transcriptionally synergizes with NF-IL6. Proc Natl Acad Sci USA 89:1473-6
22. Koga T, Duan H, Urabe K, Furue M (2002) In situ localization of CD83-positive dendritic cells in psoriatic lesions. Dermatology 204:100-3
23. Komine M, Freedberg IM, Blumenberg M (1996) Regulation of epidermal expression of keratin K17 in inflammatory skin diseases. J Invest Dermatol 107:569-75
24. Komine M, Rao LS, Keneko K, Tomic-Canic M, Tamaki K, Freedberg IM et al. (2000) Inflammatory versus proliferative processes in epidermis. tumor necrosis factor alpha induces K6b keratin synthesis through a transcriptional complex containing NF kappa B and C/EBP beta. J Biol Chem 275:32077-88
25. Lotti T, Knoepfel B, Zangheri M, Panconesi E (1992) Expression of T6 antigen on keratinocytes in alopecia areata. Int J Dermatol 31:103-6
26. Lowes MA, Chamian F, Abello MV, Fuentes-Duculan J, Lin SL, Nussbaum R et al. (2005) Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci USA 102:19057-62
27. Lutz MB, Schuler G (2002) Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends immunol 23:445-9
28. Maytin EV, Habener JF (1998) Transcription factors C/EBP alpha, C/EBP beta, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo. J Invest Dermatol 110:238-46
29. McLellan AD, Heiser A, Sorg RV, Fearnley DB, Hart DNJ (1998) Dermal dendritic cells associated with T lymphocytes in normal human skin display activated phenotype. J Invest Dermatol 111:841-9
30. Mommers JM, van Rossum MM, van Erp PE, van De Kerkhof PC (2000) Changes in keratin 6 and keratin 10 (co-)expression in lesional and symptomless skin of spreading psoriasis. Dermatology 201:15-20
31. Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O et al. (2005) Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 202:135-43
32. Ohki O, Yokozeki H, Katayama I, Umeda T, Azuma M, Okumura K et al. (1997) Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis. Br J Dermatol 136:838-45
33. Oxholm A, Oxholm P, Staberg B (1987) Reduced density of T6-positive epidermal Langerhans' cells in uninvolved skin of patients with psoriasis. Acta Derm Venereol 67:8-11
34. Schweizer J, Marks F (1977) A developmental study of the distribution and frequency of Langerhans cells in relation to formation of patterning in mouse-tail epidermis. J Invest Dermatol 69:198-204
35. Van de Kerkhof PC, Kuppens LH, Van Vlijmen Y, Schalkwijk J (1991) Distribution of skin-derived antileucoproteases (SKALP) in the marginal zone of the spreading psoriatic lesion. Br J Dermatol 124:10-2
36. Van den Oord JJ, de Wolf-Peeters C (1994) Epithelium-lining macrophages in psoriasis. Br J Dermatol 130:589-94
37. Willemze R, Dijkstra A, Nugteren WM (1985) Intercellular distribution of HLA-DR and T6 antigens in the epidermis of various dermatoses. Br J Dermatol 113:802-4
38. Wollenberg A, Wen S, Bieber T (1999) Phenotyping of epidermal dendritic cells: clinical applications of a flow cytometric micromethod. Cytometry 37:147-55
39. Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS (2003) Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 102:161-8
40. Zenz R, Eferl R, Kenner L, Florin L, Hummerich L, Mehic D et al. (2005) Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437:369-75